Europe - FRA:VIH1 - DE000A2YPDD0 - Common Stock
The current stock price of VIH1.DE is 8.95 EUR. In the past month the price increased by 19.21%. In the past year, price increased by 1.46%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
OLT.OL | OLAV THON EIENDOMSSELSKAP AS | 18.21 | 27.70B | ||
ENTRA.OL | ENTRA ASA | 20.49 | 22.91B | ||
VNA.DE | VONOVIA SE | 17.26 | 22.07B | ||
SU1N.DE | SWISS PRIME SITE-REG | 24.24 | 9.59B | ||
PUBLI.OL | PUBLIC PROPERTY INVEST AS | 10.12 | 8.74B | ||
DWNI.DE | DEUTSCHE WOHNEN SE | N/A | 8.58B | ||
CTPNV.AS | CTP NV | 7.09 | 8.50B | ||
O5G.DE | CPI PROPERTY GROUP SA | N/A | 6.88B | ||
P7S.DE | PSP SWISS PROPERTY AG-REG | 26.97 | 6.53B | ||
AT1.DE | AROUNDTOWN SA | 5.01 | 5.08B | ||
LEG.DE | LEG IMMOBILIEN SE | 12.52 | 5.03B | ||
NRP.AS | NEPI ROCKCASTLE N.V. | 8.4 | 4.84B |
VIB Vermögen AG engages in the development, acquisition, and management of commercial real estate properties. The company is headquartered in Neuburg An Der Donau, Bayern and currently employs 27 full-time employees. The company went IPO on 2018-01-25. The firm is engaged in the development, acquisition and management of commercial real estate. The focus is on properties in the logistics, light industrial and office asset classes. In addition to direct acquisitions, VIB's business model also includes in-house developments and redensification. The company acquires properties that have already been let, and it also develops new properties from scratch to permanently incorporate these into its own portfolio and generate rental income from them. Sales are an integral component of the overall strategy of the Company. In addition, VIB offers comprehensive real estate management services and solutions for institutional investors and holds interests in companies with real estate assets.
VIB VERMOEGEN AG
Tilly-Park 1
Neuburg an der Donau BAYERN DE
Employees: 29
Phone: 49843190770
The current stock price of VIH1.DE is 8.95 EUR. The price decreased by -1.21% in the last trading session.
The exchange symbol of VIB VERMOEGEN AG is VIH1 and it is listed on the Deutsche Boerse Ag exchange.
VIH1.DE stock is listed on the Deutsche Boerse Ag exchange.
7 analysts have analysed VIH1.DE and the average price target is 11.73 EUR. This implies a price increase of 31.06% is expected in the next year compared to the current price of 8.95. Check the VIB VERMOEGEN AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
VIB VERMOEGEN AG (VIH1.DE) has a market capitalization of 295.80M EUR. This makes VIH1.DE a Micro Cap stock.
VIB VERMOEGEN AG (VIH1.DE) currently has 29 employees.
VIB VERMOEGEN AG (VIH1.DE) has a support level at 8.91 and a resistance level at 9.07. Check the full technical report for a detailed analysis of VIH1.DE support and resistance levels.
The Revenue of VIB VERMOEGEN AG (VIH1.DE) is expected to grow by 13.92% in the next year. Check the estimates tab for more information on the VIH1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
VIB VERMOEGEN AG (VIH1.DE) has a dividend yield of 0.45%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of VIH1.DE dividend history, reliability and sustainability.
VIB VERMOEGEN AG (VIH1.DE) will report earnings on 2026-03-10.
The PE ratio for VIB VERMOEGEN AG (VIH1.DE) is 8.21. This is based on the reported non-GAAP earnings per share of 1.09 and the current share price of 8.95 EUR. Check the full fundamental report for a full analysis of the valuation metrics for VIH1.DE.
ChartMill assigns a technical rating of 8 / 10 to VIH1.DE. When comparing the yearly performance of all stocks, VIH1.DE is one of the better performing stocks in the market, outperforming 76.09% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to VIH1.DE. VIH1.DE has an average financial health and profitability rating.
Over the last trailing twelve months VIH1.DE reported a non-GAAP Earnings per Share(EPS) of 1.09. The EPS decreased by -72.11% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 34.63% | ||
ROA | 1.9% | ||
ROE | 4.11% | ||
Debt/Equity | 0.92 |
7 analysts have analysed VIH1.DE and the average price target is 11.73 EUR. This implies a price increase of 31.06% is expected in the next year compared to the current price of 8.95.
For the next year, analysts expect an EPS growth of 10.47% and a revenue growth 13.92% for VIH1.DE